Showing results (511-520 of 2,576) with videos related to

Sort By:
Pageof 258
Molecular Oncology|March 13, 2025
Highly multiplexed digital PCR assay for simultaneous quantification of variant allele frequencies and copy number alterations of KRAS and GNAS in pancreatic cancer precursorsJunko Tanaka, Tatsuo Nakagawa, Yusuke Ono, et al.
Molecular Oncology|October 18, 2024
Nongenetic evolution of the tumor: from challenges to new therapeutic opportunitiesElisa Oricchio
Molecular Oncology|October 14, 2024
Targeting KRAS-mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2Satoru Miyazaki, Masato Kitazawa, Satoshi Nakamura, et al.
Molecular Oncology|October 9, 2024
Transformer-based representation learning and multiple-instance learning for cancer diagnosis exclusively from raw sequencing fragments of bisulfite-treated plasma cell-free DNAJilei Liu, Hongru Shen, Yichen Yang, et al.
Molecular Oncology|September 11, 2024
Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expressionJasper Van Goubergen, Miroslav Peřina, Florian Handle, et al.
Molecular Oncology|August 9, 2024
The mevalonate pathway contributes to breast primary tumorigenesis and lung metastasisJavier Conde, Isabel Fernández-Pisonero, L Francisco Lorenzo-Martín, et al.
Molecular Oncology|August 9, 2024
Transcription factor 4 is a key mediator of oncogenesis in neuroblastoma by promoting MYC activityNour A Aljouda, Dewan Shrestha, Chelsea DeVaux, et al.
Molecular Oncology|August 7, 2024
Dynamic methylation and expression of alternative promoters for oestrogen receptor alpha in cell line models of fulvestrant resistanceJuliane Albrecht, Mirjam Müller, Völundur Hafstað, et al.
Molecular Oncology|August 2, 2024
Assessments of prostate cancer cell functions highlight differences between a pan-PI3K/mTOR inhibitor, gedatolisib, and single-node inhibitors of the PI3K/AKT/mTOR pathwayAdrish Sen, Salmaan Khan, Stefano Rossetti, et al.
Molecular Oncology|July 3, 2024
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patientsPrajwol Shrestha, Steven Kao, Veronica K Cheung, et al.
Pageof 258